19338005: 2 (qualifier value)

Status: retired, Primitive. Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

32597014 Two en Synonym Active Case insensitive SNOMED CT core

3442102012 2 (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core

3442103019 2 en Synonym Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
2	Is a	General adjectival modifier	false	Inferred relationship	Some
2	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream	Count of base of active ingredient	False	2	Inferred relationship	Some
Chlorhexidine gluconate 5 mg/mL and sodium nitrite 1 mg/mL cutaneous solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	2	Inferred relationship	Some
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Thioridazine 2 mg/mL oral solution	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Fluorescein sodium stain 2.5 mg/mL and proparacaine hydrochloride 5 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet	Has presentation strength numerator value	False	2	Inferred relationship	Some	2
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Memantine hydrochloride 2 mg/mL oral solution	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment	Count of base of active ingredient	False	2	Inferred relationship	Some
Physostigmine salicylate 5 mg/mL and pilocarpine hydrochloride 40 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Fluorometholone acetate 1 mg/mL and tobramycin 3 mg/mL eye suspension	Count of base of active ingredient	False	2	Inferred relationship	Some
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel	Count of base of active ingredient	False	2	Inferred relationship	Some
Benzoyl peroxide 25 mg/g and clindamycin phosphate 12 mg/g cutaneous gel	Count of base of active ingredient	False	2	Inferred relationship	Some
Lidocaine hydrochloride 2 mg/mL solution for injection	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Clonazepam 2 mg orodispersible tablet	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Choline 200 mg/mL and glycerol 126 mg/mL ear solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment	Count of base of active ingredient	False	2	Inferred relationship	Some
Gemcitabine (as gemcitabine hydrochloride) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocodone bitartrate 333 microgram/mL and paracetamol 33.3 mg/mL oral solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocodone bitartrate 500 microgram/mL and paracetamol 33.3 mg/mL oral solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and etidocaine hydrochloride 15 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline 10 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Fluconazole 2 mg/mL solution for injection	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Morphine sulfate 2 mg/mL oral suspension	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Adrenaline 2 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Adrenaline 2 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 5 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Hypromellose 2 mg/mL eye solution	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Adrenaline 12.5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Cefotaxime sodium 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Paracetamol 650 mg and pentazocine 25 mg oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Budesonide 160 microgram and formoterol 4.5 microgram/actuation powder for inhalation	Count of base of active ingredient	False	2	Inferred relationship	Some
Budesonide 80 microgram and formoterol 4.5 microgram/actuation powder for inhalation	Count of base of active ingredient	False	2	Inferred relationship	Some
Chlorpromazine hydrochloride 2 mg/mL oral solution	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Glucose 100 mg/mL and sodium chloride 1.8 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocortisone 2 mg/mL oral suspension	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Adrenaline 200 microgram/mL and cocaine (as cocaine hydrochloride) 50 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Benserazide 12.5 mg and levodopa 50 mg oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Benserazide 25 mg and levodopa 100 mg oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Salbutamol (as salbutamol sulfate) 2 mg/mL solution for inhalation	Has concentration strength numerator value	False	2	Inferred relationship	Some	1
Neomycin and prednisolone only product in ocular dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Betamethasone and neomycin only product in otic dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Betamethasone and neomycin only product in nasal dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocortisone and neomycin only product in otic dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Hydrocortisone and neomycin only product in ocular dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Neomycin and prednisolone only product in otic dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Acetic acid and oxyquinoline only product in vaginal dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Acetic acid and oxyquinoline only product	Count of base of active ingredient	False	2	Inferred relationship	Some
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch	Count of base of active ingredient	False	2	Inferred relationship	Some
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Amoxicillin anhydrous (as amoxicillin) 40 mg/mL and clavulanic acid (as clavulanate potassium) 5.7 mg/mL oral suspension	Count of base of active ingredient	False	2	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Cilastatin (as cilastatin sodium) 500 mg and imipenem anhydrous (as imipenem) 500 mg powder for solution for injection vial	Count of base of active ingredient	False	2	Inferred relationship	Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray	Count of base of active ingredient	False	2	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 10 mg and levodopa 100 mg orodispersible tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Cannabinol 25 mg/mL and tetrahydrocannabinol 27 mg/mL oral spray	Count of base of active ingredient	False	2	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Cefamandole (as cefamandole nafate) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial	Count of base of active ingredient	False	2	Inferred relationship	Some
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel	Count of base of active ingredient	False	2	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 200 mg and clavulanic acid (as clavulanate potassium) 28.5 mg chewable tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial	Count of base of active ingredient	False	2	Inferred relationship	Some
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial	Count of base of active ingredient	False	2	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet	Count of base of active ingredient	False	2	Inferred relationship	Some
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch	Count of base of active ingredient	False	2	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 120 mg/mL and clavulanic acid (as clavulanate potassium) 8.58 mg/mL oral suspension	Count of base of active ingredient	False	2	Inferred relationship	Some
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial	Count of base of active ingredient	False	2	Inferred relationship	Some
Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	2	Inferred relationship	Some	1
Clavulanic acid (as clavulanate potassium) 1 mg and ticarcillin (as ticarcillin disodium) 30 mg powder for solution for injection vial	Count of base of active ingredient	False	2	Inferred relationship	Some
Coal tar 25 mg/mL and lecithin 3 mg/mL shampoo	Count of base of active ingredient	False	2	Inferred relationship	Some
Salicylic acid 30 mg/mL and sulfur 50 mg/mL shampoo	Count of base of active ingredient	False	2	Inferred relationship	Some
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution	Count of base of active ingredient	False	2	Inferred relationship	Some
Mequinol and tretinoin only product in cutaneous dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Aspirin and glycine only product in oromucosal dose form	Count of base of active ingredient	False	2	Inferred relationship	Some
Loteprednol and tobramycin only product in ocular dose form	Count of base of active ingredient	False	2	Inferred relationship	Some

Start Previous Page 13 of 24 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32597014	Two	en	Synonym	Active	Case insensitive	SNOMED CT core
3442102012	2 (qualifier value)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3442103019	2	en	Synonym	Active	Case insensitive	SNOMED CT core